In recent years, especially since the COVID-19 pandemic, the healthcare and life sciences market has rapidly evolved, resulting in an unprecedented demand for highly skilled talent in this industry. As the industry struggles with a shortage of skilled workers, enterprises are increasingly partnering with Recruitment Process Outsourcing (RPO) providers to attract, hire, and retain talent. In response, RPO providers are striving to improve their talent acquisition offerings for the healthcare and life sciences industry.
Recently, WilsonHCG, a global total talent solutions provider, announced its acquisition of Personify, a US-based RPO provider specializing in the healthcare and life sciences industry. This acquisition aims to strengthen WilsonHCG’s capabilities in the sector, allowing enterprises to leverage the combined power of a global RPO participant with commendable industry expertise, a wide delivery footprint, and additional synergistic capabilities. According to Everest Group, this acquisition is crucial for the healthcare and life sciences industry, as it presents a unique set of opportunities for enterprises to overcome the talent challenges they face.
In this viewpoint, we outline the acquisition’s objectives, discuss the evolution and challenges of the healthcare and life sciences RPO market, examine the acquisition’s impact on WilsonHCG and Personify, and analyze the acquisition’s impact on the broader market.